+9.0%
GSK vs STT
+48.6%
-39.6%
-22.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | STT | Excess | Alpha |
|---|---|---|---|---|
| 1D | -1.2% | +1.5% | -2.7% | -1.4% |
| 7D | -1.1% | +0.4% | -1.5% | -1.2% |
| 30D | +7.8% | -0.4% | +8.3% | +7.8% |
| 3M | +0.3% | -6.5% | +6.8% | +0.9% |
| 6M | +3.4% | +17.2% | -13.7% | -1.3% |
| YTD | +5.9% | +38.2% | -32.3% | -3.4% |
| All | +9.0% | +48.6% | -39.6% | -1.6% |
Cumulative growth
Daily Returns
Daily percentage return beside STT.
Daily Out/Under-Performance
Portfolio return minus STT return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × STT return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded STT wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling